Label Lifecycle Management (LLM) is mission critical for global device manufacturers – if labels cannot be printed accurately, a product cannot ship and the associated costs are huge. Get it right, however, and there are major productivity gains and real economies of scale. Despite this, labeling is often an ‘orphaned’ business function within device companies; with many organizations still relying on silo’d, local systems to manage perceived local requirements.
Our recent labeling challenges survey highlighted the fact that medical device companies are increasingly waking up to the benefits that the standardization and consolidation of label management can bring, on both a global, and local, scale.
It’s easy to get caught up in the perceived complexities of varying regulatory requirements, the supposed pain of replacing existing software systems, and alleged validation of a new centralized solution – all while attempting to maintain global corporate branding. However, the fact is that as regulations tighten, the need for medical device manufacturers to examine their systems, processes and operations is intensifying in order to mitigate the increasing risk of product recalls and the resultant damage this will cause to the business.
The latest generation of global Label Lifecycle Management solutions is now created with increasing flexibility and is therefore able to accommodate the different needs of business users and stakeholders across the organization; from the ability to create and enforce corporate policy, to being able to control labels globally whilst simultaneously meeting country / regional needs, and managing regulatory compliance.
Above all, in the demanding medical device and pharmaceutical industry, deploying a thoroughly conceived enterprise wide labeling architecture minimizes risk, increases efficiency and gives organizations the dependability they need.